Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL776777 | 0.83 | TSHR (0.38) | TSHRMAPK1SMN1; SMN2GAAKMT2A | |
| SCHEMBL31468509 | 0.83 | KDM4E (0.33) | KDM4E | |
| SCHEMBL787845 | 0.83 | TSHR (0.38) | TSHRMAPK1SMN1; SMN2GAAKMT2A | |
| SCHEMBL4002631 | 0.79 | SIGMAR1 (0.33) | SMN1; SMN2SIGMAR1CXCR4POLB | |
| SCHEMBL4058410 | 0.79 | — | — | |
| SCHEMBL31687752 | 0.79 | TSHR (0.36) | TSHRMAPK1SMN1; SMN2GAAKMT2A | |
| SCHEMBL2797041 | 0.79 | SMN1; SMN2 (0.46) | TSHRMAPK1SMN1; SMN2GAAALDH1A1 | |
| SCHEMBL1859823 | 0.77 | SMN1; SMN2 (0.40) | TSHRMAPK1SMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL4070474 | 0.76 | — | — | |
| SCHEMBL19768733 | 0.75 | MAPK1 (0.33) | TSHRMAPK1SMN1; SMN2GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025547-A | Side chain amino silicone oil and preparation method thereof | 山东东岳有机硅材料股份有限公司 | 2025-05-23 | — | — | CN | disclosed |
| EP-4541800-A1 | NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2025-04-23 | — | — | EP | disclosed |
| US-20250122230-A1 | NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-8197591-B2 | Pearlescent pigments having a secondary coating comprising α-silanes and method for the production thereof | ECKART GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| EP-1904587-B8 | PEARLESCENT PIGMENTS HAVING A SECONDARY COATING COMPRISING (ALPHA)-SILANES AND METHOD FOR THE PRODUCTION THEREOF | ECKART GMBH (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-1904587-B1 | PEARLESCENT PIGMENTS HAVING A SECONDARY COATING COMPRISING -SILANES AND METHOD FOR THE PRODUCTION THEREOF | ECKART GMBH (DE) | 2010-11-03 | — | — | EP | disclosed |
| US-20090249979-A1 | PEARLESCENT PIGMENTS HAVING A SECONDARY COATING COMPRISING ALPHA-SILANES AND METHOD FOR THE PRODUCTION THEREOF | ECKART GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| EP-1904587-A2 | PEARLESCENT PIGMENTS HAVING A SECONDARY COATING COMPRISING -SILANES AND METHOD FOR THE PRODUCITON THEREOF | Eckart GmbH (DE) | 2008-04-02 | — | — | EP | disclosed |
| US-7276615-B2 | Organofunctional surface-modified metal oxides | WACKER CHEMIE AG (DE) | 2007-10-02 | — | — | US | disclosed |
| WO-2007098887-A2 | PEARLESCENT PIGMENTS HAVING A SECONDARY COATING COMPRISING α-SILANES AND METHOD FOR THE PRODUCITON THEREOF | ECKART GMBH (DE) | 2007-09-07 | — | — | WO | disclosed |
| EP-1473296-B1 | Organofunctional surface modified metal oxides | WACKER CHEMIE AG (DE) | 2006-08-02 | — | — | EP | disclosed |
| US-20040220419-A1 | Organofunctional surface-modified metal oxides | WACKER-CHEMIE GMBH (DE) | 2004-11-04 | — | — | US | disclosed |
| EP-1473296-A1 | Organofunctional surface modified metal oxides | Wacker-Chemie GmbH (DE) | 2004-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122230-A1 | NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME | HRH3, HRH4, OR10J3 | TSHR 2049/4885MAPK1 2701/4885SMN1; SMN2 1908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.